Back
Tompkins Financial Corp. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
71
TMP
Tompkins Financial Corp.
Last Price:
$74.68
Seasonality Move:
0.01%
Buy
67
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$113.68
Seasonality Move:
-9.01%
Buy
71
Tompkins Financial Corp. (TMP)
is a Buy
Is Tompkins Financial Corp. a Buy, Sell or Hold?
-
The current Tompkins Financial Corp. [TMP] share price is $74.13. The Score for TMP is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
TMP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TMP Stock Price Chart
What is Tompkins Financial Corp.'s stock price today?
-
The Tompkins Financial Corp. share price today is $74.13Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMP is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $113.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
TMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.05 | Buy |
| Relative Strength Index (14 RSI): | 66.19 | Buy |
| Chaikin Money Flow: | -57141 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.41 - 72.37) | Buy |
| Bollinger Bands (100): | (64.39 - 70.19) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 59.45 | Buy |
| Chaikin Money Flow: | -357754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.81 - 108.61) | Buy |
| Bollinger Bands (100): | (93.91 - 107.83) | Buy |
TMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.99 | Buy |
| 20-day SMA: | 69.86 | Buy |
| 50-day SMA: | 67.22 | Buy |
| 200-day SMA: | 64.9 | Buy |
| 8-day EMA: | 73.06 | Buy |
| 20-day EMA: | 70.8 | Buy |
| 50-day EMA: | 68.61 | Buy |
| 200-day EMA: | 65.92 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.1 | Buy |
| 20-day SMA: | 105.06 | Buy |
| 50-day SMA: | 105.14 | Buy |
| 200-day SMA: | 81.74 | Buy |
| 8-day EMA: | 108.55 | Buy |
| 20-day EMA: | 106.16 | Buy |
| 50-day EMA: | 103.93 | Buy |
| 200-day EMA: | 86.65 | Buy |
Tompkins Financial Corp. Earnings Growth & TMP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $1.06 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Tompkins Financial Corp. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||